However, HMGB1 might promote tumor development rather than activating immune responses against premalignant cells as chemically-induced skin and inflammation-induced liver cancer development was inhibited in mice deficient for the HMGB1 receptor RAGE (79, 80). This evidence concerns the gene HMGB1 and neoplasm.